KaydedilenlerDerginizi ekleyin

Dergiler / Turkish Journal of Biology / 2016 / Cilt: 40 - Sayı: 2

Simvastatin combined with bone marrow stromal cells treatment activatesastrocytes to ameliorate neurological function after ischemic stroke in rats

Yonghua ZHAO
Qian ZHANG
Zhenwei CHEN
Naiwei LIU
Chienchih KE
Youhua XU
Welkang WU
Sayfa
519–528
Yayın Tarihi
2022-10-17
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Therefore, we think that combination treatment should be a more effective therapy after stroke due to synergic functions of supplementary approaches.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Evidence indicates that reactive astrocytes play an important role in neurological functional amelioration after stroke.
📊
Temel Bulgular & Veri:In our present study, we established a middle cerebral artery occlusion model in rats and found that combination treatment of simvastatin and BMSCs could significantly increase neurological functional scores and induce activated astrocytes to enhance stromal cell-derived factor-1 α, vascular endothelial growth factor, brain-derived neurotrophic factor, and glial cell line-derived neurotrophic factor expressions compared with BMSC alone (P < 0.05) by immunofluorescence staining on the 7th day after ischemia.
💡
Sonuç & Katkı:Therefore, we think that combination treatment should be a more effective therapy after stroke due to synergic functions of supplementary approaches.
🔬Tür:Modelleme & Sayısal Simülasyon
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Evidence indicates that reactive astrocytes play an important role in neurological functional amelioration after stroke. Bone marrow stromal cell (BMSC) transplantation-promoted astrocyte-derived neurotrophic factors' expressions resulted in decreasing the number of apoptotic neurons and improving neurogenesis and angiogenesis in the ischemic boundary zone. Recent studies found that simvastatin had neuroprotective activity in acute stroke. However, it is still ambiguous as to whether simvastatin combined with BMSCs can further activate astrocytes, which contribute to neurological functional recovery after ischemic stroke. In our present study, we established a middle cerebral artery occlusion model in rats and found that combination treatment of simvastatin and BMSCs could significantly increase neurological functional scores and induce activated astrocytes to enhance stromal cell-derived factor-1 α, vascular endothelial growth factor, brain-derived neurotrophic factor, and glial cell line-derived neurotrophic factor expressions compared with BMSC alone (P < 0.05) by immunofluorescence staining on the 7th day after ischemia. Furthermore, western blot results showed that combination treatment could notably activate the AKT/mammalian target of rapamycin signaling pathway in oxygen-glucose deprivation-induced astrocytes. It was superior to BMSC treatment at the 5-min time point (P < 0.01). Therefore, we think that combination treatment should be a more effective therapy after stroke due to synergic functions of supplementary approaches.

🔖

Bu Makaleye Atıf Yap

ZHAO, Y., ZHANG, Q., CHEN, Z., LIU, N., KE, C., XU, Y., WU, W. (2022). Simvastatin combined with bone marrow stromal cells treatment activatesastrocytes to ameliorate neurological function after ischemic stroke in rats. Turkish Journal of Biology, Cilt: 40 - Sayı: 2, 519–528. https://ajindex.com/articles/600352

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (10)

  1. Argaw AT, Asp L, Zhang J, Navrazhina K, Pham T, Mariani JN, Mahase S, Dutta DJ, Seto J, Kramer EG et al (2012). Astrocytederived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease. J Clin Invest 122: 2454–2468.
  2. Barreto GE, Gonzalez J, Torres Y, Morales L (2011). Astrocyticneuronal crosstalk: implications for neuroprotection from brain injury. Neurosci Res 71: 107–113. Béjot Y, Prigent-Tessier A, Cachia C, Giroud M, Mossiat C, Bertrand N, Garnier P, Marie C (2011). Time-dependent contribution of non neuronal cells to BDNF production after ischemic stroke in rats. Neurochem Int 58: 102–111.
  3. Campos-Martorell M, Salvador N, Monge M, Canals F, García- Bonilla L, Hernández-Guillamon M, Ayuso MI, Chacón P, Rosell A, Alcazar A et al (2014). Brain proteomics identifies potential simvastatin targets in acute phase of stroke in a rat embolic model. J Neurochem 130: 301–312.
  4. Chen J, Cui X, Zacharek A, Chopp M (2009). Increasing Ang1/ Tie2 expression by simvastatin treatment induces vascular stabilization and neuroblast migration after stroke. J Cell Mol Med 13: 1348–1357.
  5. Chen J, Li Y, Wang L, Zhang Z, Lu D, Lu M, Chopp M (2001). Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 32: 1005–1011.
  6. Chen Y, Ai Y, Slevin JR, Maley BE, Gash DM (2005). Progenitor proliferation in the adult hippocampus and substantia nigra induced by glial cell line-derived neurotrophic factor. Exp Neurol 196: 87–95.
  7. Cui X, Chopp M, Zacharek A, Roberts C, Lu M, Savant-Bhonsale S, Chen J (2009). Chemokine, vascular and therapeutic effects of combination Simvastatin and BMSC treatment of stroke. Neurobiol Dis 36: 35–41.
  8. Gao Q, Li Y, Chopp M (2005). Bone marrow stromal cells increase astrocyte survival via upregulation of phosphoinositide 3-kinase/threonine protein kinase and mitogen-activated protein kinase kinase/extracellular signal-regulated kinase pathways and stimulate astrocyte trophic factor gene expression after anaerobic insult. Neuroscience 136: 123–134.
  9. Garcia JH, Wagner S, Liu KF, Hu XJ (1995). Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation. Stroke 26: 627– 634. Jang H, Oh MY, Kim YJ, Choi IY, Yang HS, Ryu WS, Lee SH, Yoon BW (2014). Hydrogen sulfide treatment induces angiogenesis after cerebral ischemia. J Neurosci Res 92: 1520–1528.
  10. Jin R, Zhu X, Liu L, Nanda A, Granger DN, Li G (2013). Simvastatin attenuate